IRIS
SALA, GIANLUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.760
AS - Asia 2.459
EU - Europa 2.132
Continente sconosciuto - Info sul continente non disponibili 380
SA - Sud America 346
AF - Africa 64
OC - Oceania 3
Totale 10.144
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.584
SG - Singapore 1.166
IT - Italia 701
CN - Cina 521
VN - Vietnam 313
IE - Irlanda 300
BR - Brasile 270
RU - Federazione Russa 244
SE - Svezia 196
DE - Germania 140
GB - Regno Unito 110
IN - India 92
UA - Ucraina 92
CA - Canada 82
FR - Francia 81
TR - Turchia 78
BD - Bangladesh 71
HK - Hong Kong 63
FI - Finlandia 62
PL - Polonia 32
NL - Olanda 30
AT - Austria 26
AR - Argentina 25
JP - Giappone 25
ZA - Sudafrica 25
MX - Messico 21
BE - Belgio 20
EC - Ecuador 18
IQ - Iraq 18
LT - Lituania 17
ES - Italia 16
JM - Giamaica 13
AE - Emirati Arabi Uniti 12
CZ - Repubblica Ceca 12
KR - Corea 11
MY - Malesia 11
CR - Costa Rica 10
EG - Egitto 10
IL - Israele 10
PK - Pakistan 10
VE - Venezuela 10
CH - Svizzera 9
NI - Nicaragua 9
UZ - Uzbekistan 9
GT - Guatemala 8
JO - Giordania 8
GR - Grecia 7
HN - Honduras 7
TT - Trinidad e Tobago 7
MA - Marocco 6
PY - Paraguay 6
SC - Seychelles 6
CO - Colombia 5
DK - Danimarca 5
DZ - Algeria 5
ID - Indonesia 5
CW - ???statistics.table.value.countryCode.CW??? 4
EE - Estonia 4
LK - Sri Lanka 4
RS - Serbia 4
TN - Tunisia 4
UY - Uruguay 4
AZ - Azerbaigian 3
BB - Barbados 3
BG - Bulgaria 3
CL - Cile 3
GD - Grenada 3
HR - Croazia 3
HU - Ungheria 3
KE - Kenya 3
LB - Libano 3
PE - Perù 3
PH - Filippine 3
PT - Portogallo 3
SA - Arabia Saudita 3
SV - El Salvador 3
TW - Taiwan 3
AL - Albania 2
AU - Australia 2
IR - Iran 2
MD - Moldavia 2
NP - Nepal 2
PR - Porto Rico 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BM - Bermuda 1
BO - Bolivia 1
BZ - Belize 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
Totale 9.751
Salva come PNG Salva come JPEG
Città #
Singapore 871
San Jose 564
Chandler 411
Ashburn 347
Dublin 297
Dallas 214
Jacksonville 182
Beijing 174
Council Bluffs 147
Santa Clara 122
Princeton 114
Los Angeles 109
The Dalles 108
New York 98
Ho Chi Minh City 90
Ann Arbor 85
Chieti 80
North Bergen 75
Pescara 66
Buffalo 62
Hanoi 57
Hong Kong 56
Altamura 52
Boardman 48
Munich 48
Nanjing 48
Dearborn 44
Phoenix 38
Rome 38
Izmir 36
Dong Ket 35
Orem 35
Columbus 34
Wilmington 34
Houston 32
St Louis 32
Moscow 29
Atlanta 28
Montreal 28
Milan 27
Warsaw 27
Redondo Beach 26
Denver 25
Frankfurt am Main 25
São Paulo 25
Washington 24
Tongling 23
Hefei 22
Southend 22
Tokyo 22
Lappeenranta 21
Brussels 20
Chicago 20
Brooklyn 19
Da Nang 19
Johannesburg 19
Seattle 19
Turku 19
Cambridge 16
Stockholm 16
Chennai 14
Nuremberg 14
Haiphong 13
Nanchang 13
Poplar 13
Pune 13
Collecorvino 12
Helsinki 12
London 12
Silver Spring 12
Hebei 11
L’Aquila 11
Mcallen 10
Mexico City 10
Norwalk 10
Rio de Janeiro 10
Seoul 10
Toronto 10
Vienna 10
Woodbridge 10
Charlotte 9
Managua 9
Manchester 9
Mumbai 9
Naples 9
Ninh Bình 9
San Francisco 9
Shanghai 9
Tampa 9
Tashkent 9
Vilnius 9
Boston 8
Brasília 8
Cleveland 8
Montesilvano 8
Newark 8
Petaling Jaya 8
San José 8
Shenyang 8
Vancouver 8
Totale 5.825
Salva come PNG Salva come JPEG
Nome #
LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma 250
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 239
Cold atmospheric plasma activated media selectively affects human head and neck cancer cell lines 215
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 199
BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages 191
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 188
LGALS3BP antibody-drug-conjugate and its use for the treatment of cancer 187
Proteomic meta-analysis unveils new frontiers for biomarkers research in pancreatic carcinoma 185
ABCC3 is a novel target for the treatment of pancreatic cancer 179
miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction. 178
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 174
ERBB3 BINDING ANTIBODY 171
Humanized anti-bag3 antibodies 171
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 170
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer 166
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 165
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs) 163
Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma 162
Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8(+) T cell number and tumour growth in pancreatic cancer 160
Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools 157
Development of an anti-BAG3 humanized antibody for treatment of pancreatic cancer 153
CAF-Derived IL6 and GM-CSF Cooperate to Induce M2-like TAMs–Letter 149
Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer. 146
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes 146
BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration 146
A first-in-class non-cytotoxic nanocarrier based on a recombinant human ferritin boosts targeted therapy, chemotherapy and immunotherapy 144
HPLC-DAD validated method for DM4 and its metabolite S-Me-DM4 quantification in biological matrix for clinical and pharmaceutical applications 144
Therapeutic efficacy of the novel stimuli-sensitive nano-ferritins containing doxorubicin in a head and neck cancer model 144
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target 140
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 139
Breast cancer in the era of integrating "Omics" approaches 139
LGALS3BP antibody-drug conjugate enhances tumor-infiltrating lymphocytes and synergizes with immunotherapy to restrain neuroblastoma growth 137
An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling. 130
Antibody-drug conjugates: The new frontier of chemotherapy 129
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine 128
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma 127
EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer 125
Engineered human nanoferritin bearing the drug genz-644282 for cancer therapy 125
High activity and low toxicity of a novel CD71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors 123
Phospholipase Cgamma1 is required for metastasis development and progression 122
The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor 1 122
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma 121
Human head and neck cancer cell lines response to cold atmospheric plasma activated media is affected by the chemistry of culture media 121
HER3 targeting with an antibody-drug conjugate bypasses resistance to anti-HER2 therapies 121
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer 121
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines 120
Dual PDK1/aurora kinase a inhibitors reduce pancreatic cancer cell proliferation and colony formation 119
The E27 β2-adrenergic receptor polymorphism reduces the risk of myocardial infarction in dyslipidemic young males 116
EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo. 115
A phosphoinositide 3-kinase/phospholipase cgamma1 pathway regulates fibroblast growth factor-induced capillary tube formation 115
The role of phosphoinositide 3-kinase C2α in insulin signaling 112
Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers 111
The role of phospholipase Cγ1 in breast cancer and its clinical significance 110
Evaluation of Antibody-Drug Conjugate Performances Using a Novel HPLC-DAD Method for Tumor-Specific Detection of DM4 and S-Methyl-DM4 108
Concerted BAG3 and SIRPα blockade impairs pancreatic tumor growth 108
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors 107
Endosialin-binding antibody 107
Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control 106
HER-3: Hub for escape mechanisms 103
Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin 103
Feedback inhibition by RALT controls signal output by the ErbB network 100
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate 94
Effects of an ErbB-3 antibody, MP-RM-1, on tumor growth and ligand-dependent and -independent activation of ErbB-3/akt signaling 93
Visualizing Galectin-3 Binding Protein Expression with ImmunoPET 92
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma 92
MYC regulates metabolism through vesicular transfer of glycolytic kinases 92
New analytical challenges in characterization of Antibody-Drug Conjugates 88
Negative regulation of receptor tyrosine kinase signals 86
P63 role in breast cancer 85
Galectin-3-binding protein is a risk factor for Diabetes, Metabolic Syndrome, and Inflammation. Cross-sectional and Longitudinal Results from the InCHIANTI study 84
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans 84
USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer 82
Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target 82
Role of BAG3 in cancer progression: A therapeutic opportunity 80
Therapeutic potential of antibody‐drug conjugate‐based therapy in head and neck cancer: A systematic review 75
Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker 53
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 36
BAG3 in human tumors 36
null 21
LGALS3BP is associated with selective cargo enrichment in neuroblastoma extracellular vesicles 10
null 7
Totale 10.144
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.587
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022249 0 0 0 0 18 12 13 23 29 20 28 106
2022/20231.065 94 175 71 124 92 176 49 89 129 12 38 16
2023/2024638 38 15 64 33 36 214 97 26 5 25 13 72
2024/20251.657 60 301 242 66 45 74 71 74 218 130 228 148
2025/20263.933 284 134 372 450 422 238 718 207 371 381 217 139
2026/20271.290 96 292 242 472 188 0 0 0 0 0 0 0
Totale 10.144